Elizabeth Hud

519 total citations
17 papers, 461 citations indexed

About

Elizabeth Hud is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Elizabeth Hud has authored 17 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Biochemistry, 8 papers in Nephrology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Elizabeth Hud's work include Advanced Glycation End Products research (12 papers), Chronic Kidney Disease and Diabetes (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Elizabeth Hud is often cited by papers focused on Advanced Glycation End Products research (12 papers), Chronic Kidney Disease and Diabetes (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Elizabeth Hud collaborates with scholars based in United States. Elizabeth Hud's co-authors include Margo P. Cohen, Van-Yu Wu, Clyde W. Shearman, Fuad N. Ziyadeh, Elizabeth Shea, Gregory T. Lautenslager, Margo P. Cohen, Sheldon Chen, Rex S. Clements and Dong Cheol Han and has published in prestigious journals such as Kidney International, Investigative Ophthalmology & Visual Science and Clinica Chimica Acta.

In The Last Decade

Elizabeth Hud

17 papers receiving 437 citations

Peers

Elizabeth Hud

EDM

NEPHR

PHYSI

Gregory T. Lautenslager United States

Tetsuro Arimura Japan

Kamie Snow United States

Soichi Nishishita Japan

Maikki Parkkonen Finland

Ines Cilenšek Slovenia

Daisho Hirota Japan

Yuri Ono Japan

D. B. Archer United Kingdom

Kathleen Flosseau France

Gregory T. Lautenslager United States

Elizabeth Hud

210 ×0.7

155 ×0.7

EDM

229 ×1.5

NEPHR

130 ×1.2

41 ×1.0

PHYSI

Citations per year, relative to Elizabeth Hud Elizabeth Hud (= 1×) peers Gregory T. Lautenslager

Countries citing papers authored by Elizabeth Hud

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Hud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Hud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Hud more than expected).

Fields of papers citing papers by Elizabeth Hud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Hud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Hud. The network helps show where Elizabeth Hud may publish in the future.

Co-authorship network of co-authors of Elizabeth Hud

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Hud. A scholar is included among the top collaborators of Elizabeth Hud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Hud. Elizabeth Hud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lautenslager, Gregory T., Clyde W. Shearman, Elizabeth Hud, & Margo P. Cohen. (2011). Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. Metabolism. 60(12). 1683–1691. 11 indexed citations

Cohen, Margo P., Elizabeth Hud, & Elizabeth Shea. (2010). Rate of Formation of Glycated Albumin Revisited and Clinical Implications. Journal of Diabetes & Metabolism. 1(1). 11 indexed citations

Cohen, Margo P., Elizabeth Hud, Van-Yu Wu, & Clyde W. Shearman. (2008). Amelioration of Diabetes-Associated Abnormalities in the Vitreous Fluid by an Inhibitor of Albumin Glycation. Investigative Ophthalmology & Visual Science. 49(11). 5089–5089. 29 indexed citations

Cohen, Margo P., Elizabeth Hud, Elizabeth Shea, & Clyde W. Shearman. (2007). Vitreous Fluid of <i>db/db</i> Mice Exhibits Alterations in Angiogenic and Metabolic Factors Consistent with Early Diabetic Retinopathy. Ophthalmic Research. 40(1). 5–9. 20 indexed citations

Cohen, Margo P., Gregory T. Lautenslager, Elizabeth Hud, et al.. (2006). Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. American Journal of Physiology-Renal Physiology. 292(2). F789–F795. 26 indexed citations

Cohen, Margo P., Sheldon Chen, Fuad N. Ziyadeh, et al.. (2005). Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney International. 68(4). 1554–1561. 61 indexed citations

Cohen, Margo P., Elizabeth Hud, Elizabeth Shea, & Clyde W. Shearman. (2002). Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice. Metabolism. 51(7). 901–905. 13 indexed citations

Cohen, Margo P., Fuad N. Ziyadeh, Soon Won Hong, et al.. (2002). Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1. Kidney International. 61(6). 2025–2032. 29 indexed citations

Cohen, Margo P., Fuad N. Ziyadeh, Soon Won Hong, et al.. (2002). Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.. 61(6). 2025–2032. 4 indexed citations

10.

Cohen, Margo P., et al.. (2000). Inhibiting Albumin Glycation Ameliorates Diabetic Nephropathy in the <i>db/db</i> Mouse. Nephron Experimental Nephrology. 8(3). 135–143. 33 indexed citations

11.

Cohen, Margo P., Elizabeth Hud, Van-Yu Wu, & Fuad N. Ziyadeh. (1995). Glycated albumin modified by amadori adducts modulates aortic endothelial cell biology. Molecular and Cellular Biochemistry. 143(1). 73–79. 19 indexed citations

12.

Cohen, Margo P., Elizabeth Hud, Van-Yu Wu, & Fuad N. Ziyadeh. (1995). Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Molecular and Cellular Biochemistry. 151(1). 61–67. 33 indexed citations

13.

Cohen, Margo P., Elizabeth Hud, & Van-Yu Wu. (1994). Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin. Kidney International. 45(6). 1673–1679. 53 indexed citations

14.

Hud, Elizabeth, et al.. (1994). Glycated albumin: a marker of glycaemic status in rats with experimental diabetes. Laboratory Animals. 28(1). 63–69. 3 indexed citations

15.

Cohen, Margo P. & Elizabeth Hud. (1989). Production and characterization of monoclonal antibodies against human glycoalbumin. Journal of Immunological Methods. 117(1). 121–129. 46 indexed citations

16.

Hud, Elizabeth & Margo P. Cohen. (1989). Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albumin. Clinica Chimica Acta. 185(2). 157–164. 16 indexed citations

17.

Cohen, Margo P. & Elizabeth Hud. (1989). Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. Journal of Immunological Methods. 122(2). 279–283. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact